← Back to Clinical Trials
Recruiting NCT05002166

NCT05002166 Clinical Characteristics and Risk Factors of Children Suffering From Inflammatory Bowel Diseases At Assiut University Children Hospital

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05002166
Status Recruiting
Phase
Sponsor Assiut University
Condition Inflammatory Bowel Disease
Study Type OBSERVATIONAL
Enrollment 20 participants
Start Date 2021-08-05
Primary Completion 2027-07-20

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age 18 Years
Study Type OBSERVATIONAL
Interventions
labortatory such as fecal calprotectin ,CRP,CBC,ESR. Endoscopic examination of the gastrointestinal tract Histological examination of the biopsies retrieved during gastrointestinal endoscope.

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 20 participants in total. It began in 2021-08-05 with a primary completion date of 2027-07-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Clinical Characteristics and Risk factors of Children Suffering from Inflammatory Bowel Diseases At Assiut University Children Hospital

Eligibility Criteria

Inclusion Criteria: \- Children aged less than 18 years with a confirmed diagnosis of IBD. Exclusion Criteria: * Children with colitis other than IBD or children with systemic diseases affecting GIT.

Contact & Investigator

Central Contact

Christine Zaghloul, Resident

✉ christinezaghloul@gmail.com

📞 01289132810

Principal Investigator

Shereen Mansour, Lecturer

PRINCIPAL INVESTIGATOR

Assiut University

Frequently Asked Questions

Who can join the NCT05002166 clinical trial?

This trial is open to participants of all sexes, up to 18 Years, studying Inflammatory Bowel Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05002166 currently recruiting?

Yes, NCT05002166 is actively recruiting participants. Contact the research team at christinezaghloul@gmail.com for enrollment information.

Where is the NCT05002166 trial being conducted?

This trial is being conducted at Asyut, Egypt.

Who is sponsoring the NCT05002166 clinical trial?

NCT05002166 is sponsored by Assiut University. The principal investigator is Shereen Mansour, Lecturer at Assiut University. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology